




Searching News Database: CoStar
HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
HSMN NewsFeed - 12 Mar 2008
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
HSMN NewsFeed - 17 Sep 2007
Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
HSMN NewsFeed - 7 May 2007
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
HSMN NewsFeed - 17 Jan 2007
Conor Medsystems Comments on Netherlands Court Decision on Angiotech Patent
Conor Medsystems Comments on Netherlands Court Decision on Angiotech Patent
HSMN NewsFeed - 17 Jan 2007
Boston Scientific and Angiotech Win Patent Infringement Case Against Conor in the Netherlands
Boston Scientific and Angiotech Win Patent Infringement Case Against Conor in the Netherlands
HSMN NewsFeed - 4 Jan 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
Eli Lilly and Company Statement Regarding Today's New York Times Article - January 4, 2007
HSMN NewsFeed - 4 Jan 2007
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
Lilly and Plaintiffs' Attorneys Enter Into Agreements to Settle Zyprexa(R) Product Liability Litigation
HSMN NewsFeed - 1 Dec 2006
Lilly Responds to the Cost-Effectiveness Analysis of the CATIE Schizophrenia Trial
Lilly Responds to the Cost-Effectiveness Analysis of the CATIE Schizophrenia Trial
HSMN NewsFeed - 17 Nov 2006
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
HSMN NewsFeed - 16 Nov 2006
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
HSMN NewsFeed - 5 Oct 2006
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Additional items found! 33

Members Archive contains
33 additional stories matching:
CoStar
(Password required)
CoStar
(Password required)